Washington, USA
08048034998
+919359902383

Analieva 1mg Tablet Supplier USA | Anastrozole Bulk Exporter | Ernest OncologyAnalieva 1mg Tablet Su

Global Exporter & Bulk Supplier: Analieva 1mg Tablet

🌍 Market Overview

Are you looking to optimize your commercial supply chain with a dependable, verified partner for targeted hormonal breast cancer treatments? Ernest Oncology (the premier specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd.) is a leading global exporter, wholesale bulk supplier, and distributor of Analieva 1mg Tablets.

Leveraging our advanced, fully compliant international pharmaceutical logistics network, we execute efficient, high-capacity export operations to deliver Anastrozole 1mg directly to global hospital networks, specialized oncology clinics, international pharmacy groups, and health tender boards across the USA, UK, Australia, and South Africa.



πŸ”¬ Product Profile: Analieva 1mg Tablet

Analieva 1mg contains Anastrozole, a highly potent and selective non-steroidal aromatase inhibitor. It serves as a frontline therapeutic option in endocrine-based oncology, specifically formulated to target hormone-dependent malignant pathways.

  • Active Ingredient: Anastrozole (1mg)

  • Therapeutic Class: Antineoplastic / Non-Steroidal Aromatase Inhibitor (AI)

  • Mechanism of Action: In postmenopausal women, the primary source of circulating estrogen is the conversion of adrenal androgens (such as androstenedione and testosterone) into estrone and estradiol, catalyzed by the aromatase enzyme complex in peripheral tissues. Analieva 1mg works by selectively binding to and inhibiting the aromatase enzyme. This action effectively cuts off the body's estrogen synthesis, starving estrogen receptor-positive (ER+) breast cancer cells of the primary signaling hormone they require to proliferate, migrate, and metastasize.

  • Primary Clinical Indications:

    • Adjuvant Treatment of Early Breast Cancer: Prescribed as an effective adjuvant therapy for postmenopausal women diagnosed with early-stage, hormone receptor-positive (ER+) breast cancer, significantly reducing the rate of recurrence following primary surgical resection.

    • First-Line Treatment of Advanced/Metastatic Breast Cancer: Indicated as an initial systemic intervention for postmenopausal women with locally advanced or metastatic hormone receptor-positive or hormone receptor-unknown breast cancer.

    • Second-Line Sequential Therapy: Utilized in the clinical management of advanced breast cancer in patients experiencing disease progression following initial tamoxifen therapy.

  • Administration Protocol: To maintain stable, consistent therapeutic plasma levels, the tablet should be swallowed whole with water once daily, consistently at the same time each day, with or without food.


πŸ“¦ Logistics & Sourcing Capabilities

  • Compliant Supply Lines: Sourced directly through fully validated and legal pharmaceutical manufacturing lines operating under strict global Good Manufacturing Practice (GMP) benchmarks.

  • Streamlined International Export: Specialized global logistics protocols engineered to navigate strict customs clearances, climate-controlled shipping lanes, and strict regulatory import frameworks within the USA, UK, Australia, and South Africa.

  • Institutional Sourcing Power: Fully equipped commercial infrastructure ready to fulfill high-volume wholesale requirements, long-term clinical contracts, and competitive public or private medical tenders.

  • B2B Documentation Suite: Every shipping batch is accompanied by comprehensive commercial documentation, including verified Certificates of Analysis (COA), detailed export invoice clearances, and end-to-end batch tracking.

PRESCRIPTION MEDICINE IS: YES


⚠️ Disclaimer

Analieva 1mg Tablet is a highly potent prescription endocrine-targeted medication. It must strictly be administered under the direct guidance, authorization, and ongoing medical supervision of a registered clinical oncologist or specialized endocrinologist. This informational profile is structured exclusively for international B2B trade, professional procurement officers, and global commercial pharmaceutical distribution networks; it does not constitute or replace professional medical advice.

 2026-05-19T05:48:50

Keywords